Bright Minds Book Value Per Share vs. Net Income

DRUG Stock  USD 77.75  4.73  5.73%   
Based on Bright Minds' profitability indicators, Bright Minds Biosciences may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Bright Minds' ability to earn profits and add value for shareholders.
 
Book Value Per Share  
First Reported
2010-12-31
Previous Quarter
10.74
Current Value
11.27
Quarterly Volatility
4.71909904
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
At this time, Bright Minds' Cash Per Share is most likely to increase in the upcoming years. The Bright Minds' current Net Debt To EBITDA is estimated to increase to 6.46, while Free Cash Flow Yield is projected to decrease to (0.02). The current Gross Profit is estimated to decrease to about (52.2 K)
For Bright Minds profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bright Minds to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bright Minds Biosciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bright Minds's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bright Minds Biosciences over time as well as its relative position and ranking within its peers.
Check out Investing Opportunities.
By analyzing Bright Minds' earnings estimates, investors can diagnose different trends across Bright Minds' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Bright Minds Biosciences is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
 
Interest Hikes
Bright Minds is projected to generate -1.185 in earnings per share on the 31st of December 2025. Bright Minds earnings estimates show analyst consensus about projected Bright Minds Biosciences EPS (Earning Per Share). It derives the highest and the lowest estimates based on Bright Minds' historical volatility. Many public companies, such as Bright Minds, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Bright Minds' earnings estimates, investors can diagnose different trends across Bright Minds' analyst sentiment over time as well as compare current estimates against different timeframes.
Can Biotechnology industry sustain growth momentum? Does Bright have expansion opportunities? Factors like these will boost the valuation of Bright Minds. Projected growth potential of Bright fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Bright Minds demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share
(1.31)
Return On Assets
(0.19)
Return On Equity
(0.28)
Bright Minds Biosciences's market price often diverges from its book value, the accounting figure shown on Bright's balance sheet. Smart investors calculate Bright Minds' intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Since Bright Minds' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Bright Minds' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Bright Minds should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Bright Minds' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bright Minds Biosciences Net Income vs. Book Value Per Share Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Bright Minds's current stock value. Our valuation model uses many indicators to compare Bright Minds value to that of its competitors to determine the firm's financial worth.
Bright Minds Biosciences is rated # 2 in book value per share category among its peers. It is one of the top stocks in net income category among its peers . At this time, Bright Minds' Book Value Per Share is most likely to increase in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Bright Minds by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Bright Net Income vs. Book Value Per Share

Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.

Bright Minds

Book Value per Share

 = 

Common Equity

Average Shares

 = 
7.94 X
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Bright Minds

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

 = 
(12.23 M)
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.

Bright Net Income Comparison

Bright Minds is currently under evaluation in net income category among its peers.

Bright Minds Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Bright Minds, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bright Minds will eventually generate negative long term returns. The profitability progress is the general direction of Bright Minds' change in net profit over the period of time. It can combine multiple indicators of Bright Minds, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income4.4 M2.4 M
Operating Income-12.5 M-11.9 M
Income Before Tax-11 M-10.5 M
Total Other Income Expense NetM2.1 M
Net Loss-13.5 M-12.8 M
Net Loss-11 M-10.5 M
Income Tax Expense-16.3 K-15.5 K
Net Interest Income1.7 M1.8 M
Net Loss-11 M-11.6 M
Interest Income1.7 M1.8 M
Change To Netincome744.8 K548.8 K
Net Loss(2.04)(2.15)
Income Quality 0.64  0.59 
Net Income Per E B T 0.91  0.80 

Bright Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Bright Minds. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bright Minds position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bright Minds' important profitability drivers and their relationship over time.

Bright Minds Earnings per Share Projection vs Actual

Use Bright Minds in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bright Minds position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bright Minds will appreciate offsetting losses from the drop in the long position's value.

Bright Minds Pair Trading

Bright Minds Biosciences Pair Trading Analysis

The ability to find closely correlated positions to Bright Minds could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bright Minds when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bright Minds - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bright Minds Biosciences to buy it.
The correlation of Bright Minds is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bright Minds moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bright Minds Biosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bright Minds can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Bright Minds position

In addition to having Bright Minds in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Macroaxis Picks Thematic Idea Now

Macroaxis Picks
Macroaxis Picks Theme
Daily selected watch list of stocks of large companies handpicked by Macroaxis Team based on their diversification potential. The Macroaxis Picks theme has 34 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Picks Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Bright Minds Biosciences is a strong investment it is important to analyze Bright Minds' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bright Minds' future performance. For an informed investment choice regarding Bright Stock, refer to the following important reports:
Check out Investing Opportunities.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
To fully project Bright Minds' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bright Minds Biosciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bright Minds' income statement, its balance sheet, and the statement of cash flows.
Potential Bright Minds investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Bright Minds investors may work on each financial statement separately, they are all related. The changes in Bright Minds's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bright Minds's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.